Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer, Gall Bladder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01927965
What this trial is testing

Study of Minnelide™ in Patients With Advanced GI Tumors

Who this might be right for
Advanced Gastrointestinal Tumors
Minneamrita Therapeutics LLC 45
Not applicableStudy completedNCT02649712
What this trial is testing

Unilateral Stenting Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction

Who this might be right for
CholangiocarcinomaGallbladder CarcinomaHepatocellular Carcinoma
Xuzhou Central Hospital 72
Testing effectiveness (Phase 2)Ended earlyNCT05009953
What this trial is testing

Study of Irinotecan Liposome Injection in Patients With Advanced Biliary Tract Cancer

Who this might be right for
Advanced Biliary Tract CancerIntrahepatic CholangiocarcinomaExtrahepatic Cholangiocarcinoma+1 more
CSPC Ouyi Pharmaceutical Co., Ltd. 17
Not applicableStudy completedNCT03729882
What this trial is testing

Primary EUS-GBD in Patients With Unresectable Malignant Biliary Obstruction and Cystic Duct Orifice Involvement.

Who this might be right for
Acute Cholecystitis
Instituto Ecuatoriano de Enfermedades Digestivas 22
Large-scale testing (Phase 3)Ended earlyNCT00658593
What this trial is testing

Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
NCIC Clinical Trials Group 19
Not applicableStudy completedNCT00900302
What this trial is testing

OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

Who this might be right for
Cancer
OHSU Knight Cancer Institute 98
Not applicableStudy completedNCT04352478
What this trial is testing

Incidental Cancer in Gallbladder Surgical Specimens Focus on Elderly Patients

Who this might be right for
Pathology
Dr. Ersin Arslan Education and Training Hospital 2,389
Not applicableStudy completedNCT06933576
What this trial is testing

Contribution of the EyeMAX™ 11Fr (Micro-Tech) Digital Single-Operator Cholangioscope With a Wide Working Channel

Who this might be right for
CholangiocarcinomaBiliary StenosisBile Duct Stones+1 more
Clinique Paris-Bercy 28
Testing effectiveness (Phase 2)Study completedNCT03473574
What this trial is testing

Durvalumab and Tremelimumab With Gemcitabine or Gemcitabine/Cisplatin Compared to Gemcitabine/Cisplatin in CCA Patients

Who this might be right for
CholangiocarcinomaGall Bladder CarcinomaCholangiocarcinoma Non-resectable+1 more
AIO-Studien-gGmbH 128
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07263360
What this trial is testing

Iparomlimab and Tuvonralimab Injection Combined With GemOX and Lenvatinib as Conversion Therapy for Initially Potentially Resectable Intrahepatic Cholangiocarcinoma and Gallbladder Cancer

Who this might be right for
BTC
Tianjin Medical University Cancer Institute and Hospital 29
Testing effectiveness (Phase 2)Study completedNCT00142480
What this trial is testing

Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder Cancer

Who this might be right for
Biliary Tract CancerGallbladder Adenocarcinoma
Massachusetts General Hospital 8
Testing effectiveness (Phase 2)Looking for participantsNCT05000294
What this trial is testing

Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types

Who this might be right for
Bile Duct CancerGall Bladder CancerBreast Cancer+6 more
University of Florida 29
Not applicableEnrolling By InvitationNCT06037837
What this trial is testing

Improving Surgeon Performance Measures for Robot-Assisted Surgery

Who this might be right for
Surgery
Memorial Sloan Kettering Cancer Center 1,000
Early research (Phase 1)Study completedNCT00003046
What this trial is testing

Interleukin-12 in Treating Patients With Cancer in the Abdomen

Who this might be right for
Anal CancerColorectal CancerGallbladder Cancer+2 more
M.D. Anderson Cancer Center 29
Early research (Phase 1)Study completedNCT00028496
What this trial is testing

Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the GallbladderAdenocarcinoma of the Pancreas+39 more
National Cancer Institute (NCI) 48
Not applicableStudy completedNCT04740164
What this trial is testing

A Dual Channel Supraglottic Airway Device (LMA Gastro) for Oxygenation in Patients Undergoing ERCP

Who this might be right for
Bile Duct CarcinomaGallbladder CarcinomaPancreatic Ductal Adenocarcinoma
M.D. Anderson Cancer Center 66
Not applicableStudy completedNCT02332551
What this trial is testing

Percutaneous Irreversible Electroporation to Treat Liver Cancer Close to the Gallbladder

Who this might be right for
Hepatic Carcinoma
Fuda Cancer Hospital, Guangzhou 30
Not applicableStudy completedNCT03002051
What this trial is testing

EUS-guided Transenteric Drainage With a Novel Lumen-apposing Metal Stent

Who this might be right for
Pancreatic PseudocystPancreatic NecrosisBiliary Obstruction+1 more
Chinese University of Hong Kong 114
Not applicableUnknownNCT05718115
What this trial is testing

Deep Learning Radiogenomics For Individualized Therapy in Unresectable Gallbladder Cancer

Who this might be right for
Gallbladder Cancer
Post Graduate Institute of Medical Education and Research, Chandigarh 75
Large-scale testing (Phase 3)Study completedNCT04003636
What this trial is testing

Pembrolizumab (MK-3475) Plus Gemcitabine/Cisplatin Versus Placebo Plus Gemcitabine/Cisplatin for First-Line Advanced and/or Unresectable Biliary Tract Carcinoma (BTC) (MK-3475-966/KEYNOTE-966)

Who this might be right for
Biliary Tract Carcinoma
Merck Sharp & Dohme LLC 1,069
Next Page